Cimex Lectularius or Bed Bugs : Vector of Infectious Agents and Pathogenic Role
1 other identifier
interventional
135
1 country
1
Brief Summary
During the last years, the investigators were the witness to the increase of a old emerging pest due to bed bugs (Cimex lectularius) in the world. Insecticides resistances apparitions and internationals transports increases seem to be the reasons of the pest. Cimex lectularius as vector of parasites, bacteria or virus was often suggested although not much observation are recently investigated in France. This study intends to examine the vectorial ability and the direct pathogenicity of Cimex lectularius.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 12, 2010
CompletedFirst Posted
Study publicly available on registry
March 18, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedApril 12, 2024
April 1, 2024
2 years
March 12, 2010
April 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Morphological identification of every bedbug Porterage of bacterial agents Porterage of viral agents Biomolecular identification of the insect A breeding of bedbugs Tests of sensibility in insecticides
day 1
Secondary Outcomes (1)
Study of the direct pathogenicity of lectularius C.
day 1, 7, 15 and 30
Interventions
Collection of the bedbugs and dermatological follow-up of the stings at J1 J7 J14 J21 J28
Eligibility Criteria
You may qualify if:
- voluntary Patients after reading of the information sheet and the signature of the consent
- Membership of the patient in the national insurance scheme
You may not qualify if:
- On the site of takings absence of insects and eggs evoking bedbugs of beds
- During the identification of certainty in the laboratory, the captured insects do not make parties of the family of Cimicidae
- The subjects deprived of freedom.
- Patients cancelling their consent.
- Patients violating the protocol of search(research)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Collection of the bedbugs and dermatological follow-up of the stings
Nice, 06000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pascal Delaunay, Dr
Centre Hospitalier Universitaire de Nice
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 12, 2010
First Posted
March 18, 2010
Study Start
March 1, 2010
Primary Completion
March 1, 2012
Study Completion
December 31, 2019
Last Updated
April 12, 2024
Record last verified: 2024-04